
Precision Neuromodulation Reduces Brain Atrophy and Boosts Connectivity in Alzheimer’s Patients
Sinaptica, a clinical-stage company pioneering personalized neuromodulation therapies for Alzheimer’s and other neurodegenerative diseases, has announced the publication of a study in Alzheimer’s Research & Therapy. The study utilized MRI…













